HER2 + BREAST CANCER
Clinical trials for HER2 + BREAST CANCER explained in plain language.
Never miss a new study
Get alerted when new HER2 + BREAST CANCER trials appear
Sign up with your email to follow new studies for HER2 + BREAST CANCER, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Engineered immune cells take on Hard-to-Treat breast cancer
Disease control OngoingThis early-stage study tests a new two-part treatment for people with advanced breast cancer that has stopped responding to standard therapies. Participants receive a single infusion of their own engineered immune cells (CLBR001) followed by cycles of an antibody drug (ABBV-461).…
Matched conditions: HER2 + BREAST CANCER
Phase: PHASE1 • Sponsor: Calibr, a division of Scripps Research • Aim: Disease control
Last updated May 20, 2026 11:53 UTC
-
Blood test could predict when breast cancer patients can safely stop treatment
Knowledge-focused OngoingThis study looks at using a personalized blood test (ctDNA) to detect tiny amounts of cancer DNA in 50 patients with HER2-positive metastatic breast cancer who have had a good response to anti-HER2 therapy for at least two years. The goal is to see if the test can help doctors de…
Matched conditions: HER2 + BREAST CANCER
Sponsor: Nagoya City University • Aim: Knowledge-focused
Last updated May 26, 2026 03:08 UTC